Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians

Gene

Volumn 526, Issue 2, 2013, Pages 223-227

  Jha, Ritu ^a   Gaur, Poonam ^a   Sharma, Suresh Chandra ^a   Das, Satya Narayan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Asian Indians; HMLH1; Oral cancer; SNP

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HMLH1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO; TUMOR LOCALIZATION;

ASIAN INDIANS; BENZO(A)PYRENE DIOL EPOXIDE; BPDE; DNA REPAIR CAPACITY; DRC; GT-IIB; GT-MOTIF 2B; HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME; HMLH1; HNPCC; HUMAN MUTL HOMOLOG 1; INTERLEUKIN 6-REGULATORY NUCLEAR FACTOR; MISMATCH REPAIR; MMR; MSH2; MUTS HOMOLOG 2; NF-IL6; ORAL CANCER; ORAL SQUAMOUS CELL CARCINOMA; OSCC; PCR-RFLP; POLYMERASE CHAIN REACTION-RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; UICC; UNION FOR INTERNATIONAL CANCER CONTROL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TOBACCO, SMOKELESS; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 84880749914     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.05.014     Document Type: Article

References (34)

1. Baniasadi V., Narain N., Goswami R., Das S.N. Promoter region -318 C/T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 2006, 67:383-389.
2. Barnes D.E. DNA damage: air-breaks?. Curr. Biol. 2002, 12:R262-R264.
3. Beiner M.E., et al. Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1636-1640.
4. Bernstein C., Bernstein H., Payne C.M., Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 2002, 511:145-178.
5. Bharti V., Mohanti B.K., Das S.N. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population. Hum. Immunol. 2013, 74:348-352.
6. Dixon K., Kopras E. Genetic alterations and DNA repair in human carcinogenesis. Semin. Cancer Biol. 2004, 14:441-448.
7. Ferlay J., Shin H.R., Bray D., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 2010, International Agency for Research on Cancer, Lyon, France, (Available from: http://globocan.iarc.fr. accessed on 25 August 2012).
8. Gaur P., Mittal M., Mohanti B.K., Das S.N. Functional variants of IL4 and IL6 genes and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Oral Dis. 2011, 17:720-726.
9. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1513-1530.
10. Gupta R., Sharma S.C., Das S.N. Association of TNF-α and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco related oral carcinoma in Asian Indians. Oral Oncol. 2008, 44:445-463.
11. Harley I., et al. Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1. Gynecol. Oncol. 2008, 109:384-387.
12. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 2003, 3:733-744.
13. Ianzano L., Zhao X.C., Minassian B.A., Scherer S.W. Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product. Genomics 2003, 81:579-587.
14. Ilyas M., Straub J., Tomlinson I.P., Bodmer W.F. Genetic pathways in colorectal and other cancers. Eur. J. Cancer 1999, 35:1986-2002.
15. Ito E., et al. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem. Biophys. Res. Commun. 1999, 256:488-494.
16. Jiricny J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 2006, 7:335-346.
17. Karimi M.Y., Kapoor V., Sharma S.C., Das S.N. Genetic polymorphisms in FAS (CD95) and FAS ligand (CD178) promoters and risk of tobacco-related oral carcinoma: gene-gene interactions in high-risk Indians. Cancer Invest. 2013, 31:1-6.
18. Kinoshita S., Akira S., Kishimoto T. A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1473-1476.
19. Lee K.-M., et al. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin. Cancer Res. 2005, 11:4620-4626.
20. Lo Y.-L., et al. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers. Lung Cancer 2011, 72:280-286.
21. Mitchell R.J., Farrington S.M., Dunlop M.G., Campbell H. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am. J. Epidemiol. 2002, 156:885-902.
22. Mittal M., Kapoor V., Mohanti B.K., Das S.N. Functional variants of COX-2 and risk of tobacco-related oral squamous cell carcinoma in high-risk Asian Indians. Oral Oncol. 2010, 46:622-626.
23. Mrkonjic M., et al. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer. PLoS One 2010, 5:e13314.
24. Park S.H., et al. -93G>A polymorphism of hMLH1 and risk of primary lung cancer. Int. J. Cancer 2004, 112:678-682.
25. Perera S., Mrkonjic M., Rawson J.B., Bapat B. Functional effects of the MLH1 -93G>A polymorphism on MLH1/EPM2AIP1 promoter activity. Oncol. Rep. 2011, 25:809-815.
26. Qiao Y., et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat. Res. 2002, 509:165-174.
27. Raptis S., et al. MLH1-93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J. Natl. Cancer Inst. 2007, 99:463-474.
28. Sobin L.H. UICC, TNM Classification of Malignant Tumors 2002, Wiley-Liss, New York. 6th edn. C. Wittekind (Ed.).
29. Sturgis E.M., Wei Q., Spitz M.R. Descriptive epidemiology and risk factors for head and neck cancer. Semin. Oncol. 2004, 31:726-733.
30. Tang M.S., Pierce J.R., Doisy R.P., Nazimiec M.E., MacLeod M.C. Differences and similarities in the repair of two benzo[a]pyrene diol epoxide isomers induced DNA adducts by uvrA, uvrB, and uvrC gene products. Biochemistry 1992, 31:8429-8436.
31. Wang Y., et al. Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling. Cancer Cell 2006, 10:179-190.
32. Wehner M., et al. Hereditary nonpolyposis colorectal cancer (HNPCC): eight novel germline mutations in hMSH2 or hMLH1 genes. Hum. Mutat. 1997, 10:241-244.
33. Yu J.-H., Bigler J., Whitton J., Potter J.D., Ulrich C.M. Mismatch repair polymorphisms and colorectal polyps: hMLH1 -93G>A variant modifies risk associated with smoking. Am. J. Gastroenterol. 2006, 101:1313-1319.
34. Zenke M., et al. Multiple sequence motifs are involved in SV40 enhancer function. EMBO J. 1986, 5:387-397.